{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:51Z","timestamp":1790959191551,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,26]]},"DOI":"10.7759\/cureus.49429","type":"journal-article","created":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T08:46:51Z","timestamp":1700988411000},"source":"Crossref","is-referenced-by-count":20,"title":["A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma"],"prefix":"10.7759","author":[{"given":"Mahitha","family":"Lampimukhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabarak","family":"Qassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakshaya","family":"Venu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"Pakhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchita","family":"Mylavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharindu","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beeran S","family":"Sathar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73 Suppl 1","author":"McGlynn KA","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021, 73 Suppl 1:4-13. 10.1002\/hep.31288","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang JD","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019, 16:589-604. 10.1038\/s41575-019-0186-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-424. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32723","article-title":"International trends in hepatocellular carcinoma incidence, 1978-2012","volume":"147","author":"Petrick JL","year":"2020","unstructured":"Petrick JL, Florio AA, Znaor A, et al.. International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer. 2020, 147:317-30. 10.1002\/ijc.32723","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_200939","article-title":"Global epidemiology, prevention, and management of hepatocellular carcinoma","volume":"38","author":"Mak LY","year":"2018","unstructured":"Mak LY, Cruz-Ram\u00f3n V, Chinchilla-L\u00f3pez P, et al.. Global epidemiology, prevention, and management of hepatocellular carcinoma. Am Soc Clin Oncol Educ Book. 2018, 38:262-79. 10.1200\/EDBK_200939","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.05.013","article-title":"Epidemiology of hepatocellular carcinoma in India","volume":"4","author":"Acharya SK","year":"2014","unstructured":"Acharya SK. Epidemiology of hepatocellular carcinoma in India. J Clin Exp Hepatol. 2014, 4:S27-33. 10.1016\/j.jceh.2014.05.013","journal-title":"J Clin Exp Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.13040\/IJPSR.0975-8232.9(12).5050-59","article-title":"Epidemiology of hepatocellular carcinoma","volume":"9","author":"Siddiqui MA","year":"2018","unstructured":"Siddiqui MA, Siddiqui HH, Mishra A, Usmani A. Epidemiology of hepatocellular carcinoma. Int J Pharm Sci Res. 2018, 9:5050-9. 10.13040\/IJPSR.0975-8232.9(12).5050-59","journal-title":"Int J Pharm Sci Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2018.06.01","article-title":"Liver cancer incidence and mortality in China: temporal trends and projections to 2030","volume":"30","author":"Zheng R","year":"2018","unstructured":"Zheng R, Qu C, Zhang S, et al.. Liver cancer incidence and mortality in China: temporal trends and projections to 2030. Chin J Cancer Res. 2018, 30:571-9. 10.21147\/j.issn.1000-9604.2018.06.01","journal-title":"Chin J Cancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1260","article-title":"Epidemiology, genotype distribution, prognosis, control, and management of viral hepatitis B, C, D, and hepatocellular carcinoma in mongolia","volume":"8","author":"Baatarkhuu O","year":"2018","unstructured":"Baatarkhuu O, Gerelchimeg T, Munkh-Orshikh D, Batsukh B, Sarangua G, Amarsanaa J. Epidemiology, genotype distribution, prognosis, control, and management of viral hepatitis B, C, D, and hepatocellular carcinoma in mongolia. Euroasian J Hepatogastroenterol. 2018, 8:57-62. 10.5005\/jp-journals-10018-1260","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1261","article-title":"Liver cancer in Nepal","volume":"8","author":"Shrestha A","year":"2018","unstructured":"Shrestha A. Liver cancer in Nepal. Euroasian J Hepatogastroenterol. 2018, 8:63-5. 10.5005\/jp-journals-10018-1261","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2012.27.2.121","article-title":"Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia","volume":"27","author":"Jazag A","year":"2012","unstructured":"Jazag A, Puntsagdulam N, Chinburen J. Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia. Korean J Intern Med. 2012, 27:121-7. 10.3904\/kjim.2012.27.2.121","journal-title":"Korean J Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: new trends","volume":"72","author":"Singal AG","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J Hepatol. 2020, 72:250-61. 10.1016\/j.jhep.2019.08.025","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal A","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011, 61:69-90. 10.3322\/caac.20107","journal-title":"CA Cancer J Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag HB","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012, 142:1264-1273.e1. 10.1053\/j.gastro.2011.12.061","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006835","article-title":"The association between hepatitis B mutants and hepatocellular carcinoma: a meta-analysis","volume":"96","author":"Wei F","year":"2017","unstructured":"Wei F, Zheng Q, Li M, Wu M. The association between hepatitis B mutants and hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore). 2017, 96:e6835. 10.1097\/MD.0000000000006835","journal-title":"Medicine (Baltimore)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti LG","year":"2006","unstructured":"Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol. 2006, 1:23-61. 10.1146\/annurev.pathol.1.110304.100230","journal-title":"Annu Rev Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya K","year":"1998","unstructured":"Moriya K, Fujie H, Shintani Y, et al.. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998, 4:1065-7. 10.1038\/2053","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/path.4434","article-title":"The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets","volume":"235","author":"Ringelhan M","year":"2015","unstructured":"Ringelhan M, O'Connor T, Protzer U, Heikenwalder M. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. J Pathol. 2015, 235:355-67. 10.1002\/path.4434","journal-title":"J Pathol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis","volume":"14","author":"Gomaa AI","year":"2008","unstructured":"Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008, 14:4300-8. 10.3748\/wjg.14.4300","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27969","article-title":"World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma","volume":"62","author":"de Martel C","year":"2015","unstructured":"de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015, 62:1190-200. 10.1002\/hep.27969","journal-title":"Hepatology"},{"key":"ref21","unstructured":"Global hepatitis report 2017. (2017). Accessed. June 18, 2023: https:\/\/www.who.int\/publications\/i\/item\/9789241565455."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27978","article-title":"Toward a more accurate estimate of the prevalence of hepatitis C in the United States","volume":"62","author":"Edlin BR","year":"2015","unstructured":"Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, Swan T. Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015, 62:1353-63. 10.1002\/hep.27978","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: a global view","volume":"7","author":"Yang JD","year":"2010","unstructured":"Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 2010, 7:448-58. 10.1038\/nrgastro.2010.100","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz JF","year":"2006","unstructured":"Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006, 45:529-38. 10.1016\/j.jhep.2006.05.013","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30983","article-title":"Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein","volume":"122","author":"Okuda M","year":"2002","unstructured":"Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology. 2002, 122:366-75. 10.1053\/gast.2002.30983","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9011","article-title":"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention","volume":"355","author":"Tomasetti C","year":"2017","unstructured":"Tomasetti C, Li L, Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science. 2017, 355:1330-4. 10.1126\/science.aaf9011","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21196","article-title":"Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma","volume":"43","author":"Branda M","year":"2006","unstructured":"Branda M, Wands JR. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology. 2006, 43:891-902. 10.1002\/hep.21196","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.36","article-title":"Viral hepatocarcinogenesis","volume":"29","author":"Tsai WL","year":"2010","unstructured":"Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene. 2010, 29:2309-24. 10.1038\/onc.2010.36","journal-title":"Oncogene"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409722102","article-title":"Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma","volume":"102","author":"Campbell JS","year":"2005","unstructured":"Campbell JS, Hughes SD, Gilbertson DG, et al.. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2005, 102:3389-94. 10.1073\/pnas.0409722102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato F","year":"2002","unstructured":"Donato F, Tagger A, Gelatti U, et al.. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol. 2002, 155:323-31. 10.1093\/aje\/155.4.323","journal-title":"Am J Epidemiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015","volume":"3","author":"Akinyemiju T","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, et al.. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017, 3:1683-91. 10.1001\/jamaoncol.2017.3055","journal-title":"JAMA Oncol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2191","article-title":"Molecular mechanisms of alcohol-mediated carcinogenesis","volume":"7","author":"Seitz HK","year":"2007","unstructured":"Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007, 7:599-612. 10.1038\/nrc2191","journal-title":"Nat Rev Cancer"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh147","article-title":"The MTHFR 677C &gt; T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis","volume":"25","author":"Saffroy R","year":"2004","unstructured":"Saffroy R, Pham P, Chiappini F, et al.. The MTHFR 677C &amp;gt; T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis. 2004, 25:1443-8. 10.1093\/carcin\/bgh147","journal-title":"Carcinogenesis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12270","article-title":"Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies","volume":"10","author":"Abdel-Rahman O","year":"2017","unstructured":"Abdel-Rahman O, Helbling D, Sch\u00f6b O, et al.. Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: An updated systematic review of 81 epidemiological studies. J Evid Based Med. 2017, 10:245-54. 10.1111\/jebm.12270","journal-title":"J Evid Based Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i38.6098","article-title":"Heavy smoking and liver","volume":"12","author":"El-Zayadi AR","year":"2006","unstructured":"El-Zayadi AR. Heavy smoking and liver. World J Gastroenterol. 2006, 12:6098-101. 10.3748\/wjg.v12.i38.6098","journal-title":"World J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010180","article-title":"Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan","volume":"151","author":"Mori M","year":"2000","unstructured":"Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, Naramoto J. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol. 2000, 151:131-9. 10.1093\/oxfordjournals.aje.a010180","journal-title":"Am J Epidemiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0702","article-title":"Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy","volume":"15","author":"Franceschi S","year":"2006","unstructured":"Franceschi S, Montella M, Polesel J, et al.. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev. 2006, 15:683-9. 10.1158\/1055-9965.EPI-05-0702","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-013-9573-8","article-title":"New insights on non-B non-C hepatocellular carcinoma in mid Delta Region, Egypt","volume":"45","author":"Abou El Azm AR","year":"2014","unstructured":"Abou El Azm AR, Yousef M, Mansour N, Awad A, El Dardiry S, Abdel Aziz I. New insights on non-B non-C hepatocellular carcinoma in mid Delta Region, Egypt. J Gastrointest Cancer. 2014, 45:276-83. 10.1007\/s12029-013-9573-8","journal-title":"J Gastrointest Cancer"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2016.07.011","article-title":"Exposure to inorganic arsenic can lead to gut microbe perturbations and hepatocellular carcinoma","volume":"6","author":"Choiniere J","year":"2016","unstructured":"Choiniere J, Wang L. Exposure to inorganic arsenic can lead to gut microbe perturbations and hepatocellular carcinoma. Acta Pharm Sin B. 2016, 6:426-9. 10.1016\/j.apsb.2016.07.011","journal-title":"Acta Pharm Sin B"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2016.6046","article-title":"Non\u2011infective occupational risk factors for hepatocellular carcinoma: a review (Review)","volume":"15","author":"Ledda C","year":"2017","unstructured":"Ledda C, Loreto C, Zammit C, et al.. Non\u2011infective occupational risk factors for hepatocellular carcinoma: a review (Review). Mol Med Rep. 2017, 15:511-33. 10.3892\/mmr.2016.6046","journal-title":"Mol Med Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2004.08.025","article-title":"Effect of chronic intake of arsenic-contaminated water on liver","volume":"206","author":"Mazumder DN","year":"2005","unstructured":"Mazumder DN. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol Appl Pharmacol. 2005, 206:169-75. 10.1016\/j.taap.2004.08.025","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/61.2.314","article-title":"Stress-related gene expression in mice treated with inorganic arsenicals","volume":"61","author":"Liu J","year":"2001","unstructured":"Liu J, Kadiiska MB, Liu Y, Lu T, Qu W, Waalkes MP. Stress-related gene expression in mice treated with inorganic arsenicals. Toxicol Sci. 2001, 61:314-20. 10.1093\/toxsci\/61.2.314","journal-title":"Toxicol Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.1.151","article-title":"Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway","volume":"23","author":"Qu W","year":"2002","unstructured":"Qu W, Bortner CD, Sakurai T, Hobson MJ, Waalkes MP. Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway. Carcinogenesis. 2002, 23:151-9. 10.1093\/carcin\/23.1.151","journal-title":"Carcinogenesis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1006\/taap.2000.8963","article-title":"Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action","volume":"166","author":"Waalkes MP","year":"2000","unstructured":"Waalkes MP, Keefer LK, Diwan BA. Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action. Toxicol Appl Pharmacol. 2000, 166:24-35. 10.1006\/taap.2000.8963","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2003.07.009","article-title":"Mechanism of arsenic carcinogenesis: an integrated approach","volume":"533","author":"Rossman TG","year":"2003","unstructured":"Rossman TG. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res. 2003, 533:37-65. 10.1016\/j.mrfmmm.2003.07.009","journal-title":"Mutat Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9193247","article-title":"Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents","volume":"93","author":"Huff J","year":"1991","unstructured":"Huff J, Cirvello J, Haseman J, Bucher J. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect. 1991, 93:247-70. 10.1289\/ehp.9193247","journal-title":"Environ Health Perspect"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-010-0583-6","article-title":"Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders","volume":"345","author":"Chaturvedi NK","year":"2010","unstructured":"Chaturvedi NK, Kumar S, Negi S, Tyagi RK. Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders. Mol Cell Biochem. 2010, 345:291-308. 10.1007\/s11010-010-0583-6","journal-title":"Mol Cell Biochem"},{"key":"ref48","article-title":"Bioassay of 4-chloro-o-toluidine hydrochloride for possible carcinogenicity","volume":"165","year":"1979","unstructured":"Bioassay of 4-chloro-o-toluidine hydrochloride for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser. 1979, 165.1-123.","journal-title":"Natl Cancer Inst Carcinog Tech Rep Ser"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay J","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al.. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015, 136:E359-86. 10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler WE","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007, 317:121-4. 10.1126\/science.1140485","journal-title":"Science"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0283","article-title":"Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis","volume":"21","author":"Ma WL","year":"2014","unstructured":"Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer. 2014, 21:R165-82. 10.1530\/ERC-13-0283","journal-title":"Endocr Relat Cancer"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy151.018","article-title":"Clinic-pathological pattern of hepatocellular carcinoma (HCC) in Egypt","volume":"29","author":"Elghazaly H","year":"2018","unstructured":"Elghazaly H, Gaballah A, Eldin NB. Clinic-pathological pattern of hepatocellular carcinoma (HCC) in Egypt. Ann Oncol. 2018, 29:5-6. 10.1093\/annonc\/mdy151.018","journal-title":"Ann Oncol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0066","article-title":"Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies","volume":"17","author":"Wang Y","year":"2012","unstructured":"Wang Y, Wang B, Shen F, Fan J, Cao H. Body mass index and risk of primary liver cancer: a meta-analysis of prospective studies. Oncologist. 2012, 17:1461-8. 10.1634\/theoncologist.2012-0066","journal-title":"Oncologist"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle EE","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 348:1625-38. 10.1056\/NEJMoa021423","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0803020","article-title":"Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study","volume":"29","author":"Batty GD","year":"2005","unstructured":"Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, Smith GD. Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes (Lond). 2005, 29:1267-74. 10.1038\/sj.ijo.0803020","journal-title":"Int J Obes (Lond)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001269","article-title":"The association between body mass index and the prognosis and postoperative complications of hepatocellular carcinoma: a meta-analysis","volume":"94","author":"Rong X","year":"2015","unstructured":"Rong X, Wei F, Geng Q, Ruan J, Shen H, Li A, Luo R. The association between body mass index and the prognosis and postoperative complications of hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore). 2015, 94:e1269. 10.1097\/MD.0000000000001269","journal-title":"Medicine (Baltimore)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2014.01.011","article-title":"Obesity-associated mechanisms of hepatocarcinogenesis","volume":"63","author":"Karagozian R","year":"2014","unstructured":"Karagozian R, Derd\u00e1k Z, Baffy G. Obesity-associated mechanisms of hepatocarcinogenesis. Metabolism. 2014, 63:607-17. 10.1016\/j.metabol.2014.01.011","journal-title":"Metabolism"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.07.012","article-title":"Nutrients intake and the risk of hepatocellular carcinoma in Italy","volume":"43","author":"Polesel J","year":"2007","unstructured":"Polesel J, Talamini R, Montella M, et al.. Nutrients intake and the risk of hepatocellular carcinoma in Italy. Eur J Cancer. 2007, 43:2381-7. 10.1016\/j.ejca.2007.07.012","journal-title":"Eur J Cancer"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600775","article-title":"Vegetables and fruit intake and cancer mortality in the Hiroshima\/Nagasaki Life Span Study","volume":"88","author":"Sauvaget C","year":"2003","unstructured":"Sauvaget C, Nagano J, Hayashi M, Spencer E, Shimizu Y, Allen N. Vegetables and fruit intake and cancer mortality in the Hiroshima\/Nagasaki Life Span Study. Br J Cancer. 2003, 88:689-94. 10.1038\/sj.bjc.6600775","journal-title":"Br J Cancer"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.8.1369","article-title":"The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism","volume":"19","author":"Cavin C","year":"1998","unstructured":"Cavin C, Holzh\u00e4user D, Constable A, Huggett AC, Schilter B. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis. 1998, 19:1369-75. 10.1093\/carcin\/19.8.1369","journal-title":"Carcinogenesis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i10.2379","article-title":"Liver cell adenoma with malignant transformation: a case report","volume":"9","author":"Ito M","year":"2003","unstructured":"Ito M, Sasaki M, Wen CY, et al.. Liver cell adenoma with malignant transformation: a case report. World J Gastroenterol. 2003, 9:2379-81. 10.3748\/wjg.v9.i10.2379","journal-title":"World J Gastroenterol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.15386\/mpr-1228","article-title":"Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989-2016","volume":"92","author":"Valean S","year":"2019","unstructured":"Valean S, Acalovschi M, Dumitrascu DL, Ciobanu L, Nagy G, Chira R. Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989-2016. Med Pharm Rep. 2019, 92:99-105. 10.15386\/mpr-1228","journal-title":"Med Pharm Rep"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw JE","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010, 87:4-14. 10.1016\/j.diabres.2009.10.007","journal-title":"Diabetes Res Clin Pract"},{"key":"ref64","article-title":"Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts","volume":"7","author":"Moore MA","year":"1998","unstructured":"Moore MA, Park CB, Tsuda H. Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts. Eur J Cancer Prev. 1998, 7:89-107.","journal-title":"Eur J Cancer Prev"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940101)73:1<42::aid-cncr2820730109>3.0.co;2-d","article-title":"Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients","volume":"73","author":"Hsu H","year":"1994","unstructured":"Hsu H, Peng S, Lai , et al.. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer. 1994, 73:42-7. 10.1002\/1097-0142(19940101)73:1&lt;42::aid-cncr2820730109&gt;3.0.co;2-d","journal-title":"Cancer"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi Z","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al.. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018, 15:11-20. 10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i18.2155","article-title":"Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma","volume":"7","author":"Khan FZ","year":"2015","unstructured":"Khan FZ, Perumpail RB, Wong RJ, Ahmed A. Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma. World J Hepatol. 2015, 7:2155-61. 10.4254\/wjh.v7.i18.2155","journal-title":"World J Hepatol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.199661","article-title":"Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications","volume":"59","author":"Stickel F","year":"2010","unstructured":"Stickel F, Hellerbrand C. Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications. Gut. 2010, 59:1303-7. 10.1136\/gut.2009.199661","journal-title":"Gut"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0112-0","article-title":"Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis","volume":"44","author":"Kawada N","year":"2009","unstructured":"Kawada N, Imanaka K, Kawaguchi T, et al.. Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. J Gastroenterol. 2009, 44:1190-4. 10.1007\/s00535-009-0112-0","journal-title":"J Gastroenterol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C> G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu YL","year":"2014","unstructured":"Liu YL, Patman GL, Leathart JB, et al.. Carriage of the PNPLA3 rs738409 C&gt; G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. J Hepatol. 2014, 61:75-81. 10.1016\/j.jhep.2014.02.030","journal-title":"J Hepatol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315193","article-title":"CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity","volume":"67","author":"Fujiwara N","year":"2018","unstructured":"Fujiwara N, Nakagawa H, Enooku K, et al.. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut. 2018, 67:1493-504. 10.1136\/gutjnl-2017-315193","journal-title":"Gut"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0229","article-title":"JCAD promotes progression of nonalcoholic steatohepatitis to liver cancer by inhibiting LATS2 kinase activity","volume":"77","author":"Ye J","year":"2017","unstructured":"Ye J, Li TS, Xu G, Zhao YM, Zhang NP, Fan J, Wu J. JCAD promotes progression of nonalcoholic steatohepatitis to liver cancer by inhibiting LATS2 kinase activity. Cancer Res. 2017, 77:5287-300. 10.1158\/0008-5472.CAN-17-0229","journal-title":"Cancer Res"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S16316","article-title":"Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics","volume":"4","author":"Dhanasekaran R","year":"2012","unstructured":"Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 2012, 4:19-37. 10.2147\/HMER.S16316","journal-title":"Hepat Med"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.7042","article-title":"Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma","volume":"12","author":"Topic A","year":"2012","unstructured":"Topic A, Ljujic M, Radojkovic D. Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma. Hepat Mon. 2012, 12:e7042. 10.5812\/hepatmon.7042","journal-title":"Hepat Mon"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2010.00663.x","article-title":"Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency","volume":"40","author":"Marcus NY","year":"2010","unstructured":"Marcus NY, Brunt EM, Blomenkamp K, Ali F, Rudnick DA, Ahmad M, Teckman JH. Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency. Hepatol Res. 2010, 40:641-53. 10.1111\/j.1872-034X.2010.00663.x","journal-title":"Hepatol Res"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.19.9014","article-title":"A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency","volume":"91","author":"Wu Y","year":"1994","unstructured":"Wu Y, Whitman I, Molmenti E, Moore K, Hippenmeyer P, Perlmutter DH. A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency. Proc Natl Acad Sci U S A. 1994, 91:9014-8. 10.1073\/pnas.91.19.9014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI16787","article-title":"Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury","volume":"110","author":"Perlmutter DH","year":"2002","unstructured":"Perlmutter DH. Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest. 2002, 110:1579-83. 10.1172\/JCI16787","journal-title":"J Clin Invest"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(89)90045-8","article-title":"Hepatic injury in chronic iron overload. Role of lipid peroxidation","volume":"70","author":"Bacon B","year":"1989","unstructured":"Bacon B, Britton R. Hepatic injury in chronic iron overload. Role of lipid peroxidation. Chem Biol Interact\r\n. 1989, 70:183-226. 10.1016\/0009-2797(89)90045-8","journal-title":"Chem Biol Interact"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2004.09.019","article-title":"Iron, hemochromatosis, and hepatocellular carcinoma","volume":"127","author":"Kowdley KV","year":"2004","unstructured":"Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology. 2004, 127:S79-86. 10.1016\/j.gastro.2004.09.019","journal-title":"Gastroenterology"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1159\/000343856","article-title":"Hepatic iron overload and hepatocellular carcinoma","volume":"3","author":"Kew MC","year":"2014","unstructured":"Kew MC. Hepatic iron overload and hepatocellular carcinoma. Liver Cancer. 2014, 3:31-40. 10.1159\/000343856","journal-title":"Liver Cancer"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04732.x","article-title":"Hepatocellular carcinoma in the thalassaemia syndromes","volume":"124","author":"Borgna-Pignatti C","year":"2004","unstructured":"Borgna-Pignatti C, Vergine G, Lombardo T, et al.. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol. 2004, 124:114-7. 10.1046\/j.1365-2141.2003.04732.x","journal-title":"Br J Haematol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24794","article-title":"Family history of liver cancer and hepatocellular carcinoma","volume":"55","author":"Turati F","year":"2012","unstructured":"Turati F, Edefonti V, Talamini R, et al.. Family history of liver cancer and hepatocellular carcinoma. Hepatology. 2012, 55:1416-25. 10.1002\/hep.24794","journal-title":"Hepatology"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnci.2016.06.001","article-title":"Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: a single center study","volume":"28","author":"Ziada DH","year":"2016","unstructured":"Ziada DH, El Sadany S, Soliman H, et al.. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: a single center study. J Egypt Natl Canc Inst. 2016, 28:257-62. 10.1016\/j.jnci.2016.06.001","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref84","article-title":"Overall evaluations of carcinogenicity: an updating of IARC monographs, vol. 1 to 42","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"1987","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Overall evaluations of carcinogenicity: an updating of IARC monographs, vol. 1 to 42. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, Lyon (FR); 1987. 1-440."},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijheh.2005.02.002","article-title":"P53 mutations in hepatocellular carcinoma patients in Egypt","volume":"208","author":"El-Kafrawy SA","year":"2005","unstructured":"El-Kafrawy SA, Abdel-Hamid M, El-Daly M, et al.. P53 mutations in hepatocellular carcinoma patients in Egypt. Int J Hyg Environ Health. 2005, 208:263-70. 10.1016\/j.ijheh.2005.02.002","journal-title":"Int J Hyg Environ Health"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.011","article-title":"Global trends and predictions in hepatocellular carcinoma mortality","volume":"67","author":"Bertuccio P","year":"2017","unstructured":"Bertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, Malvezzi M, Negri E. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol. 2017, 67:302-9. 10.1016\/j.jhep.2017.03.011","journal-title":"J Hepatol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-017-3526-7","article-title":"Trends in the mortality of hepatocellular carcinoma in the United States","volume":"21","author":"Beal EW","year":"2017","unstructured":"Beal EW, Tumin D, Kabir A, et al.. Trends in the mortality of hepatocellular carcinoma in the United States. J Gastrointest Surg. 2017, 21:2033-8. 10.1007\/s11605-017-3526-7","journal-title":"J Gastrointest Surg"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06167.x","article-title":"Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements","volume":"25","year":"2010","unstructured":"Prevention of hepatocellular carcinoma in the Asia-Pacific region. consensus statements. J Gastroenterol Hepatol. 2010, 25:657-63. 10.1111\/j.1440-1746.2009.06167.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik L","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019, 156:477-491.e1. 10.1053\/j.gastro.2018.08.065","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/189721-a-review-of-incidence-and-related-risk-factors-in-the-development-of-hepatocellular-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:51:51Z","timestamp":1707490311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/189721-a-review-of-incidence-and-related-risk-factors-in-the-development-of-hepatocellular-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,26]]},"references-count":89,"URL":"https:\/\/doi.org\/10.7759\/cureus.49429","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,26]]}}}